The sphingolipid ceramide, a bioeffector lipid, is known to regulate anti-proliferative and stress responses in various human cancer cells. Studies from this project have defined a novel pathway for the generation of ceramide, 'the salvage pathway', which involves activation of acid sphingomyelinase (aSMase). Interestingly, our preliminary results show that the cytotoxic agents cisplatin, doxorubicin, and paclitaxel exert significant effects on the adhesion and migration of cancer cells, at sub-toxic concentrations. Importantly, these results suggest an important role for the aSMase/ceramide pathway in regulating these responses. These data and insights lead us to the HYPOTHESIS that the aSMase/ceramide pathway is an important mediator of stress inducers, with key roles in regulating cell migration and metastasis. Therefore, 3 specific aims are proposed: 1) To define molecular mechanisms of activation of aSMase. We will focus on defining a) the role of PKC3 as an upstream kinase in regulation of aSMase;b) the biochemical and cellular mechanisms by which phosphorylation activates the enzyme;and c) the cellular compartment where aSMase is activated. 2) To determine the role of aSMase in tumor growth and metastasis and response to chemotherapy by: a) establishing the role of aSMase/ceramide in cell adhesion/migration of cancer cells;b) examining and defining the role of this pathway in tumor metastasis/growth in vivo. 3) To determine the mechanisms by which the aSMase/ceramide pathway mediates cell stress responses. Understanding this pathway should have great impact on the field of ceramide-mediated biology precisely by beginning to untangle the complexity of these pathways through provision of pathway-specific insight. Equally as important, defining upstream and downstream components of this pathway, which is activated by agents of significant therapeutic value, may result in defining novel therapeutic targets in cancer therapy. Finally, there is the tantalizing possibility that the role of this pathway in inhibition of cell migration in response to chemotherapeutic agents may lead to a re-examination of therapeutically relevant actions of these agents by focusing on their effects on migration and metastasis rather than on cytotoxicity or proliferation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
7P01CA097132-10
Application #
8381023
Study Section
Special Emphasis Panel (ZCA1-RPRB-O)
Project Start
Project End
2014-07-31
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
10
Fiscal Year
2012
Total Cost
$191,961
Indirect Cost
$37,225
Name
State University New York Stony Brook
Department
Type
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Chen, Jennifer Y; Newcomb, Benjamin; Zhou, Chan et al. (2017) Tricyclic Antidepressants Promote Ceramide Accumulation to Regulate Collagen Production in Human Hepatic Stellate Cells. Sci Rep 7:44867
Janecke, Andreas R; Xu, Ruijuan; Steichen-Gersdorf, Elisabeth et al. (2017) Deficiency of the sphingosine-1-phosphate lyase SGPL1 is associated with congenital nephrotic syndrome and congenital adrenal calcifications. Hum Mutat 38:365-372
Xu, Ruijuan; Garcia-Barros, Monica; Wen, Sally et al. (2017) Tumor suppressor p53 links ceramide metabolism to DNA damage response through alkaline ceramidase 2. Cell Death Differ :
Espaillat, Mel Pilar; Kew, Richard R; Obeid, Lina M (2017) Sphingolipids in neutrophil function and inflammatory responses: Mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis. Adv Biol Regul 63:140-155
McCracken, A N; McMonigle, R J; Tessier, J et al. (2017) Phosphorylation of a constrained azacyclic FTY720 analog enhances anti-leukemic activity without inducing S1P receptor activation. Leukemia 31:669-677
Pulkoski-Gross, Michael J; Uys, Joachim D; Orr-Gandy, K Alexa et al. (2017) Novel sphingosine kinase-1 inhibitor, LCL351, reduces immune responses in murine DSS-induced colitis. Prostaglandins Other Lipid Mediat 130:47-56
Coant, Nicolas; Sakamoto, Wataru; Mao, Cungui et al. (2017) Ceramidases, roles in sphingolipid metabolism and in health and disease. Adv Biol Regul 63:122-131
Hernández-Corbacho, María José; Salama, Mohamed F; Canals, Daniel et al. (2017) Sphingolipids in mitochondria. Biochim Biophys Acta 1862:56-68
Bai, Aiping; Mao, Cungui; Jenkins, Russell W et al. (2017) Anticancer actions of lysosomally targeted inhibitor, LCL521, of acid ceramidase. PLoS One 12:e0177805
Lin, Chih-Li; Xu, Ruijuan; Yi, Jae Kyo et al. (2017) Alkaline Ceramidase 1 Protects Mice from Premature Hair Loss by Maintaining the Homeostasis of Hair Follicle Stem Cells. Stem Cell Reports 9:1488-1500

Showing the most recent 10 out of 194 publications